Prelude Capital Management, LLC Liquidia Corp Transaction History
Prelude Capital Management, LLC
- $1.85 Billion
- Q1 2024
A detailed history of Prelude Capital Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 24,732 shares of LQDA stock, worth $292,579. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,732
Previous 75,081
67.06%
Holding current value
$292,579
Previous $903,000
59.69%
% of portfolio
0.02%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding LQDA
# of Institutions
157Shares Held
35.5MCall Options Held
1.68MPut Options Held
1.17M-
Patient Square Capital LP Menlo Park, CA7.18MShares$85 Million45.11% of portfolio
-
Black Rock Inc. New York, NY3.75MShares$44.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$34.2 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.25MShares$26.6 Million3.48% of portfolio
-
Findell Capital Management LLC New York, NY2.11MShares$24.9 Million16.28% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $761M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...